IVERIC BIO, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2007-01-01
- Employees
- 163
- Market Cap
- -
- Website
- http://www.ivericbio.com
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best
Tenpoint Therapeutics and Visus Therapeutics merge to focus on ophthalmic therapeutics, including BRIMOCHOLâ„¢ PF for presbyopia, with a US launch planned for 1H 2026. The merger involves a syndicate of investors and appoints Henric Bjarke as CEO, aiming to advance innovative treatments for presbyopia, cataracts, and geographic atrophy.
© Copyright 2024. All Rights Reserved by MedPath